Clinical Trial Update: Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a safety study of calcineurin inhibitor-free graft-versus-host disease prophylaxis in patients undergoing allogeneic stem cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: University Hospital Freiburg | Conditions: Hematologic Diseases | Phase 1, Phase 2 | Status: UNKNOWN